Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

942 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Morrow DA, et al. Among authors: libby p. Am Heart J. 2008 Jan;155(1):49-55. doi: 10.1016/j.ahj.2007.08.018. Epub 2007 Nov 1. Am Heart J. 2008. PMID: 18082488 Free PMC article. Clinical Trial.
Molecular determinants of atherosclerotic plaque vulnerability.
Libby P, Geng YJ, Sukhova GK, Simon DI, Lee RT. Libby P, et al. Ann N Y Acad Sci. 1997 Apr 15;811:134-42; discussion 142-5. doi: 10.1111/j.1749-6632.1997.tb51996.x. Ann N Y Acad Sci. 1997. PMID: 9186592 Review. No abstract available.
Inflammation and thrombosis: the clot thickens.
Libby P, Simon DI. Libby P, et al. Circulation. 2001 Apr 3;103(13):1718-20. doi: 10.1161/01.cir.103.13.1718. Circulation. 2001. PMID: 11282900 No abstract available.
Soluble CD40L and cardiovascular risk in women.
Schönbeck U, Varo N, Libby P, Buring J, Ridker PM. Schönbeck U, et al. Among authors: libby p. Circulation. 2001 Nov 6;104(19):2266-8. doi: 10.1161/hc4401.099447. Circulation. 2001. PMID: 11696462
Soluble CD40L: risk prediction after acute coronary syndromes.
Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Varo N, et al. Among authors: libby p. Circulation. 2003 Sep 2;108(9):1049-52. doi: 10.1161/01.CIR.0000088521.04017.13. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912804
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators. Kinlay S, et al. Among authors: libby p. Circulation. 2003 Sep 30;108(13):1560-6. doi: 10.1161/01.CIR.0000091404.09558.AF. Epub 2003 Sep 15. Circulation. 2003. PMID: 12975259 Clinical Trial.
942 results